The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
- 1 June 1999
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 13 (9), 1099-1107
- https://doi.org/10.1097/00002030-199906180-00014
Abstract
To correlate self-reported antiretroviral adherence with virologic suppression. Prospective observational study of adherence to therapy nested in a randomized comparative trial of frequent versus infrequent monitoring of plasma HIV RNA. Five university-affiliated HIV clinics. A group of173 HIV-infected patients with a mean baseline CD4 count of 142¥106 cells/l (range 3-515) of whom 164 and 119 completed adherence questionnaires at 2 and 6 months, respectively. Individualized, unrestricted antiretroviral therapy. Patients were classified into four groups by adherence to therapy in the previous 4 weeks (<80%, 80-95%, 95-99%, 100%). Plasma HIV RNA levels and CD4 lymphocyte counts were measured bimonthly. Recreational drug or alcohol use was associated with decreased adherence, whereas frequency of HIV RNA monitoring, demographic variables, (age, gender, education, and risk group) and stage of disease had no effect. Greater HIV suppression at 6 months was seen across four categories of increasing adherence (P=0.009 for linear trend). Patients reporting <80% adherence at 6 months had a 0.2 log10 copies/ml increase in HIV RNA and a loss of 19¥106 CD4 cells/l compared with a 1.1 log10 copies/ml decrease in HIV RNA and an increase of 72¥106 CD4 cells/l in those reporting 100% adherence (P=0.02). Self-reported poor adherence (<80%) and drug or alcohol use predicted non-response of HIV RNA at 6 months of antiretroviral therapy.Keywords
This publication has 17 references indexed in Scilit:
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatmentsAIDS, 1997
- Patient compliance and drug failure in protease inhibitor monotherapyPublished by American Medical Association (AMA) ,1996
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing complianceAIDS Care, 1996
- Zidovudine adherence among individuals with HIV infectionAIDS Care, 1995
- Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitorsAntimicrobial Agents and Chemotherapy, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- A cohort study of drug users' compliance with zidovudine treatmentArchives of Internal Medicine, 1994